Surely a drilling flow thru CR now would be OUR last oppo given rule change ( as I understand it) in 2025 as we would be busy raising elements of funding or scrip for the Renard transaction late this year and next?
- Forums
- ASX - By Stock
- WR1
- Ann: Investor Presentation - Pathway to Production
Ann: Investor Presentation - Pathway to Production, page-46
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WR1 (ASX) to my watchlist
|
|||||
Last
47.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.7M |
Open | High | Low | Value | Volume |
48.0¢ | 48.5¢ | 46.5¢ | $137.1K | 290.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 77785 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 19999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30046 | 0.480 |
1 | 8000 | 0.475 |
4 | 45522 | 0.465 |
1 | 6600 | 0.460 |
3 | 33680 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 19999 | 1 |
0.480 | 64353 | 4 |
0.485 | 2731 | 2 |
0.490 | 13309 | 1 |
0.495 | 15800 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
WR1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online